STABLE-MATES
Phase 3 Recruiting
272 enrolled
StrateGlio
Phase 3 Recruiting
486 enrolled
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Phase 3 Recruiting
380 enrolled
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Phase 3 Recruiting
500 enrolled
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
Phase 3 Recruiting
608 enrolled
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Phase 3 Recruiting
298 enrolled
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
Phase 3 Recruiting
186 enrolled
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
Phase 3 Recruiting
650 enrolled
NoLEEta
Phase 3 Recruiting
3,902 enrolled
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
Phase 3 Recruiting
266 enrolled
SPARAGMOS
Phase 3 Recruiting
70 enrolled
MUSIC-Screen
Phase 3 Recruiting
1,284 enrolled
TIMELY-PLEX
Phase 3 Recruiting
382 enrolled
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
Phase 3 Recruiting
616 enrolled
LEVEL
Phase 3 Recruiting
120 enrolled
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
Phase 3 Recruiting
593 enrolled
TRIBE-C
Phase 3 Recruiting
528 enrolled
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Phase 3 Recruiting
580 enrolled
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
Phase 3 Recruiting
420 enrolled
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Phase 3 Recruiting
360 enrolled
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Phase 3 Recruiting
600 enrolled
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Phase 3 Recruiting
364 enrolled
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Phase 3 Recruiting
382 enrolled
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Phase 3 Recruiting
1,295 enrolled
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Phase 3 Recruiting
421 enrolled
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Phase 3 Recruiting
1,100 enrolled
STRIKE
Phase 3 Recruiting
1,040 enrolled
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Phase 3 Recruiting
1,260 enrolled
HOPE
Phase 3 Recruiting
228 enrolled
GAIN-BCG
Phase 3 Recruiting
330 enrolled
Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma
Phase 3 Recruiting
180 enrolled
FOBEAR
Phase 3 Recruiting
582 enrolled
DEBRA
Phase 3 Recruiting
1,670 enrolled
OFSET
Phase 3 Recruiting
3,960 enrolled
HEAL-ABC
Phase 3 Recruiting
402 enrolled
OPTIFLAP
Phase 3 Recruiting
348 enrolled
CIME
Phase 3 Recruiting
132 enrolled
RePaIr-HN
Phase 3 Recruiting
214 enrolled
Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients
Phase 3 Recruiting
240 enrolled
Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.
Phase 3 Recruiting
134 enrolled
A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
Phase 3 Recruiting
910 enrolled
Selective Neck Dissection Versus Modified Neck Dissection in PTC
Phase 3 Recruiting
250 enrolled
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
Phase 3 Recruiting
124 enrolled
CAPIcorn
Phase 3 Recruiting
250 enrolled
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Phase 3 Recruiting
70 enrolled
PAROLA
Phase 3 Recruiting
510 enrolled
BRAINS
Phase 3 Recruiting
408 enrolled
POWER II
Phase 3 Recruiting
354 enrolled
T-START-M1
Phase 3 Recruiting
68 enrolled
Zilucoplan for Severe gMG Exacerbations
Phase 3 Recruiting
15 enrolled